Adherence to the guidelines of the CCCE in the treatment of node-positive breast cancer patients
- 1 January 2004
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 40 (2) , 198-204
- https://doi.org/10.1016/s0959-8049(03)00660-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Quality of adjuvant chemotherapy in primary breast cancer in a non-trial setting. A comprehensive cancer centre studyEuropean Journal Of Cancer, 1999
- Stage at Diagnosis and Treatment Patterns Among Older Women With Breast CancerJAMA, 1999
- Development of clinical guidelinesThe Lancet, 1998
- Postoperative Radiotherapy in High-Risk Premenopausal Women with Breast Cancer Who Receive Adjuvant ChemotherapyNew England Journal of Medicine, 1997
- An outcomes management program in gynecologic oncologyObstetrics & Gynecology, 1997
- The Sequencing of Chemotherapy and Radiation Therapy after Conservative Surgery for Early-Stage Breast CancerNew England Journal of Medicine, 1996
- Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil in Node-Positive Breast Cancer — The Results of 20 Years of Follow-upNew England Journal of Medicine, 1995
- Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast CarcinomaNew England Journal of Medicine, 1994
- Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluationsPublished by Elsevier ,1993
- Dose-Response Effect of Adjuvant Chemotherapy in Breast CancerNew England Journal of Medicine, 1981